Like Porterhouse Medical Group

closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2009 via BusinessWire

URCH Publishing, Ltd., acquired Spectra Intelligence

synopsis: URCH Publishing Ltd, a well-respected and established publisher of quality market intelligence reports covering the global pharmaceutical and healthcare industry, acquired Spectra Intelligence, a privately owned publisher of specialised and syndicated pharmaceutical market research.
buyer: URCH Publishing, Ltd.
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. The company is based in London, UK. "
target: Spectra Intelligence
Spectra Intelligence was founded in 2005 to provide syndicated market research information to the global life sciences industry and capital investment sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via

Decision Resources, Inc., purchased Life Sciences business from Wood Mackenzie

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that it plans to acquire Wood Mackenzie's Life Sciences business.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
seller: Wood Mackenzie
Wood Mackenzie has been providing its unique range of consulting services and research products to the Energy and Life Sciences industries for over 30 years. Our market proposition is based on our ability to provide forward- looking insight that enables our clients to make better business decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2019 via BusinessWire

W2O Group, acquired ISO.health

synopsis: W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, announced the acquisition of ISO.health, a London-based medical communications agency.
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: ISO.health
ISO.health is a London-based medical communications agency. ISO comprises a talented team of industry experts who are adept at developing and delivering impactful omni-channel medical and scientific educational programs for pharmaceutical, biotech and life sciences companies and organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2009 via BusinessWire

IntrinsiQ, acquired WWMR, Inc.

synopsis: IntrinsiQ, the company improving the quality and understanding of cancer care, announced the acquisition of market research and consulting firm WWMR, Inc. The combination creates the single, go-to source for pharmaceutical companies seeking to understand the true drivers behind physicians’ cancer treatment decisions.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details for nearly 20,000 unique patients. "
target: WWMR, Inc.
WWMR is a marketing research and strategic consulting firm founded in 1994, providing insightful, proprietary studies to pharmaceutical, biotech, medical device, and diagnostics companies worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,465.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2020 via BNC Analysis

Waterland Private Equity Investments, acquired Integrated Medhealth Communication

synopsis: Dutch firm Waterland Private Equity has bought a significant majority stake in UK-based consultancy Integrated Medhealth Communication (IMC). IMC provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally.
buyer: Waterland Private Equity Investments
Based in the Netherlands, Waterland is an independent private equity investment group that supports entrepreneurs in realising their growth ambitions. Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. "
target: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2020 via PR Newswire

Ruder Finn, Inc., acquired jacobstahl

synopsis: Global independent PR agency Ruder Finn announced that it has acquired jacobstahl, a full-service public relations agency specializing in healthcare (Rx and OTC), health and well being, consumer and corporate communications. jacobstahl was founded in 2003.
buyer: Ruder Finn, Inc.
Ruder Finn is one of the largest independent global communications and creative agencies with headquarters in the US and China. It is organized around four strategic pillars that reflect its key areas of leadership: Health & Wellness, Corporate & Public Trust, Global Connectivity, and Life & Style. "
target: jacobstahl
jacobstahl is a full-service agency specializing in healthcare (Rx and OTC), health and well being, consumer and corporate communications. jacobstahl was founded in 2003.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2020 via BNC Analysis

Waterland Private Equity Investments, acquired Integrated Medhealth Communication

synopsis: Dutch firm Waterland Private Equity has bought a significant majority stake in UK-based consultancy Integrated Medhealth Communication (IMC). IMC provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally.
buyer: Waterland Private Equity Investments
Based in the Netherlands, Waterland is an independent private equity investment group that supports entrepreneurs in realising their growth ambitions. Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. "
target: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/1/2020 via Company Press Release

Clayton, Dubilier & Rice, Inc., acquired Huntsworth PLC

synopsis: CD&R Artemis UK Bidco Ltd, an entity formed by US private equity Clayton Dubilier & Rice LLP, is to acquire Huntsworth PLC, an international healthcare and communications group. The Group's principal area of focus is Health, which provides marketing and medical communications services to healthcare clients.
buyer: Clayton, Dubilier & Rice, Inc.
Clayton, Dubilier & Rice (CD&R) is a private investment firm with a strategy predicated on producing financial returns by building stronger, more profitable businesses. Since inception, CD&R has managed the investment of $28 billion in 84 businesses. The Firm has offices in New York and London. "
target: Huntsworth PLC (LSE:HNT:$342.69)
Huntsworth PLC is an international healthcare and communications group. The Group's principal area of focus is Health, which provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies.
price ($mm)[EV]
$516 [$665]
rev ($mm)
$342
EBITDA ($mm)
$70
EV / rev
2.1x
EV / EBITDA
10.3x
closed 10/1/2019 via BusinessWire

M Booth, purchased US Division from Health Unlimited

synopsis: Next15 has acquired US division of Health Unlimited, a leading global health consultancy and communications agency advancing landmark developments in some of the most complex and challenging areas in health. Health Unlimited will be rebranded as M Booth Health and operate as a separate agency reporting to M Booth CEO Dale Bornstein.
buyer parent: Next 15
buyer: M Booth
M Booth is an agency that is known for award-winning integrated marketing programs that engage stakeholders through digital, social, earned media, and experiential channels. M Booth is a wholly owned subsidiary of the Next Fifteen Communications Group. "
seller parent: Dbay Advisors
seller: Health Unlimited
Health Unlimited US Division, rebranded M Booth Health, is a 25-year-old NY-based global health consultancy and communications agency built by specialists with a legacy of advancing landmark developments in global health and medicine.
price ($mm)
$28
rev ($mm)
$17
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 12/4/2018 via BusinessWire

Open Health merged with Peloton Advantage,

synopsis: Amulet Capital Partners, a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced that it has acquired OPEN Health, a multi-disciplinary health communications and market access group. Amulet plans to merge OPEN Health with its existing portfolio company, Peloton Advantage.
buyer parent: Amulet Capital Partners LP
buyer: Peloton Advantage
Peloton Advantage, LLC is a medical communications company specializing in strategic publication planning and associated content development for medical education programs. "
target parent: Providence Equity Partners Inc.
target: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating within four core business areas: Medical Communications; Patient and Brand Communications; Value, Informatics and Evidence; Consulting and Commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/19/2018 via BNC Analysis

Cello Health Communications, purchased Healthcare Team from Firstlight Public Relations

synopsis: Cello Health Communications has acquired the ten-strong healthcare team at Firstlight Public Relations. Firstlight’s healthcare team, which was established in 2011 by Pat Pearson, will now be called Cello Health Public Relations and is located in central London. Firstlight's healthcare team provides healthcare public relations services.
buyer parent: Cello Health plc
buyer: Cello Health Communications
Cello Health Communications provides the full range of evidence through engagement solutions to biopharma, device, diagnostic and consumer companies through the synergistic blend of their strategic, scientific and creative expertise. "
seller: Firstlight Public Relations
Firstlight’s healthcare team, which was established in 2011 by Pat Pearson, provides healthcare public relations services. Firstlight Public Relations is a UK-based full service public relations agency with extensive experience in corporate, B2B, and healthcare communications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2015 via PR Newswire

Havas Health, acquired Just:: Health Communications

synopsis: Havas Health announced the acquisition of Just:: Health Communications, a leading London agency known for its innovative work and for providing services to global clients in public relations, medical communications, public affairs and digital communications.
buyer parent: Bolloré
buyer: Havas Health
The Havas Health network has a uniquely unified model offering strategy, promotion, medical education, market access, PR and digital solutions inside each agency asset. "
target: Just:: Health Communications
Just:: is a healthcare agency that is committed to working with ambitious, people who share its desire to ask questions, break new ground and make a positive impact. Just:: prides itself on giving confident, honest advice and creating powerful campaigns that resonate with clients and stakeholders.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2015 via GlobeNewswire

A.D.A.M., Inc., acquired Via Media Health

synopsis: Ebix, Inc., a leading supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, announced that it has acquired Via Media Health, one of India's leading health content & communication companies. Via Media Health will be immediately integrated into its A.D.A.M. Health Information Exchange Division.
buyer parent: Ebix, Inc.
buyer: A.D.A.M., Inc. (ADAM:$0.00)
Founded in 1990, A.D.A.M., Animated Dissection of Anatomy for Medicine, has been a worldwide leading provider of consumer health information and benefits technology solutions to health care organizations, hospitals, benefits brokers, employers, consumers, and educational institutions. "
target: Via Media Health
Via Media Health is a 13 years old communication, consulting, and networking organization focused on innovative health communication solutions in India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/27/2020 via BNC Analysis

Prime Global Medical Communications Ltd., acquired Cambridge Medical Communication

synopsis: Prime Global has bought Cambridge Medical Communication in a deal that will see the UK-based company join its stable of six agencies and two consultancies. Cambridge Medical Communication is an independent medical communications agency based near Cambridge, UK.
buyer: Prime Global Medical Communications Ltd.
Prime Global is a group of seven full-service Medical Communications agencies and two specialist consultancies. They provide the world’s leading biotech, pharma and healthcare businesses with professional communications and strategic consultancy services. "
target: Cambridge Medical Communication
Cambridge Medical Communication is an independent medical communications agency based near Cambridge, UK. Founded in 1998 by Managing Director, Jenny Muiry PhD, Cambridge Medical Communication has built up a formidable reputation for providing clear and imaginative medical communication materials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/12/2018 via BusinessWire

ICR, acquired Continuum Health Communications

synopsis: ICR, a leading strategic communications and advisory firm serving more than 500 private and public company clients, has acquired Continuum Health Communications, an integrated communications agency specializing in strategy and corporate and product communications.
buyer: ICR
ICR partners with companies to optimize transactions and execute strategic communications programs that achieve business goals, build credibility and enhance long-term enterprise value. ICR is one of the largest and most experienced independent communications and advisory firms in North America. "
target: Continuum Health Communications
Continuum Health Communications is an integrated communications agency specializing in strategy and corporate and product communications. They work across the industry from pharma and biotech, to device and diagnostics, to B2B technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BNC Analysis

United Drug plc, acquired Watermeadow

synopsis: United Drug plc (UD) announced that it has acquired the entire issued share capital of Watermeadow Medical Ltd and Watermeadow Medical Consulting Inc for a total consideration of up to £13m. Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Watermeadow
Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US. It provides services to global pharmaceutical companies, including medical writing and preparation of promotional and educational materials typically for products pre-launch.
price ($mm)
$9.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2012 via GlobeNewswire

Paul Werth Associates, acquired Generations Sync

synopsis: Paul Werth Associates, an integrated communications firm based in Columbus, Ohio, has acquired Generations Sync, a Chicago-based boutique firm specializing in health care public relations and direct marketing. Generations Sync is immediately changing its name to Paul Werth Associates.
buyer: Paul Werth Associates
Paul Werth Associates is an independent, full-service communications firm that helps grow businesses, launch brands and shape strategies for some of the Midwest's leading organizations. Its competencies include public relations, public affairs, marketing and branding, B2B advertising, and research. "
target: Generations Sync
Generations Sync is a boutique firm specializing in health care public relations and direct marketing. It produces stronger brands and loyal customers by integrating emerging technologies with traditional disciplines such as strategy, promotional education, and direct marketing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2019 via BusinessWire

W2O Group, acquired ISO.health

synopsis: W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, announced the acquisition of ISO.health, a London-based medical communications agency.
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: ISO.health
ISO.health is a London-based medical communications agency. ISO comprises a talented team of industry experts who are adept at developing and delivering impactful omni-channel medical and scientific educational programs for pharmaceutical, biotech and life sciences companies and organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via PR Newswire

Court Square Capital Partners, acquired Medical Knowledge Group LLC

synopsis: WindRose Health Investors, LLC, the New York-based healthcare private equity firm, has completed the recapitalization of its portfolio company, Medical Knowledge Group, by investment funds managed by Court Square Capital Partners. Medical Knowledge Group provides specialized medical communications and market research services.
buyer: Court Square Capital Partners
Court Square is a middle market private equity firm with one of the most experienced investment teams in the industry. Since 1979, the team has completed over 230 investments, including several landmark transactions, and has developed numerous businesses into leaders in their respective markets. "
target parent: WindRose Health Investors
target: Medical Knowledge Group LLC
Medical Knowledge Group, through its operating companies, provides specialized medical communications services, proprietary analytic solutions, and market research services to the biopharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2019 via BNC Analysis

Fishawack Group, acquired 2e Creative

synopsis: 2e Creative, an internationally recognized healthcare marketing strategy firm focused on launching pharmaceutical and medical device products has joined the Fishawack Group, one of UK's largest independent medical communications and medical marketing specialists.
buyer: Fishawack Group
UK-based Fishawack Group is one of the largest independent medical communications and medical marketing specialists. It comprises of Fishawack Medical Communications, offering services in medical communications, and Fishawack Creative, offering strategic planning, development, and advertising. "
target: 2e Creative
2e Creative is a launch and growth agency featuring Fortune 50 clients across pharma, medical device, and research biotech. The agency’s core competencies include branding, marketing strategy, digital marketing, sales training, and meeting/event production.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2018 via BusinessWire

Fishawack Group, acquired Blue Latitude Health

synopsis: The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. BLH focuses on the commercialization of healthcare innovations.
buyer: Fishawack Group
Based in the UK, the Fishawack Group of Companies is one of the largest independent medical communications specialists with offices in the UK, USA, Switzerland, and India. For over 17 years, they have been partnering with global and regional pharmaceutical, biotechnology, and medical device clients."
target: Blue Latitude Health
Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. Focused on the commercialization of healthcare innovations, they operate globally and regionally at a brand, portfolio and organizational level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

MTS Health Investors, LLC, acquired Medical Knowledge Group LLC

synopsis: MTS Health Investors, LLC the NY-based healthcare private equity firm, announced that funds managed by MTS have completed a recapitalization of Medical Knowledge Group, LLC. Medical Knowledge Group is an analytics-driven and technology-enabled multi-channel healthcare marketing and communications provider servicing the biopharmaceutical industry.
buyer: MTS Health Investors, LLC
MTS Health Investors, LLC, located in New York, is a healthcare private equity firm that makes investments in operating companies within the healthcare industry. MTS focuses on companies that deliver greater value for every dollar spent in healthcare. "
target parent: CIVC Partners, LP
target: Medical Knowledge Group LLC
Medical Knowledge Group is a New York based, independent analytics-driven and technology-enabled multi-channel marketing solutions provider serving marketing, medical affairs, and stakeholder relations teams at biopharmaceutical companies throughout the entire product lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Porterhouse Medical Group


read more

Porterhouse Medical Group

Spectra Intelligence

Wood Mackenzie

Elysia Group

ISO.health

Double Helix

Rood Research, Inc.

Verispan, LLC

Pharmerit International

KMR Group

WWMR, Inc.

The Nielsen Company, Inc.

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

SDI Health LLC

InforMed Direct

BioTrends Research Group, Inc.

Eidetics

Arlington Medical Resources Inc.

read more

Porterhouse Medical Group

read more

Porterhouse Medical Group

Integrated Medhealth Communication

read more

Porterhouse Medical Group

jacobstahl

Integrated Medhealth Communication

90Ten

Huntsworth PLC

Health Unlimited

Open Health

Firstlight Public Relations

Just:: Health Communications

Via Media Health

Cambridge Medical Communication

Continuum Health Communications

Watermeadow

Generations Sync

ISO.health

BresMed Health Solutions Ltd

Medical Knowledge Group LLC

2e Creative

Blue Latitude Health

Medical Knowledge Group LLC

Geography
Matching Companies
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch